Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro

Autor: Sara Scapolan, Maria Anna Donati, Federico Zara, Marina Pedemonte, Elisabetta Gazzerro, Xiabo Wang, Monica Traverso, Stefania Assereto, Laura Giberti, Claudio Bruno, Federica Sotgia, Silvia Stringara, Roberta Biancheri, Carlo Minetti, Elisabetta Pasquini, Michael P. Lisanti
Rok vydání: 2008
Předmět:
Male
Caveolin 3
Mutant
medicine.disease_cause
Muscular Dystrophies
Methionine
Caveolae
Chlorocebus aethiops
Caveolin
Protein Isoforms
Missense mutation
Fluorescent Antibody Technique
Indirect

Genes
Dominant

Mutation
Histocytochemistry
Homozygote
Middle Aged
Immunohistochemistry
Phenotype
COS Cells
cardiovascular system
Female
Adult
Cardiomyopathy
Dilated

medicine.medical_specialty
Green Fluorescent Proteins
Mutation
Missense

Genes
Recessive

In Vitro Techniques
Biology
Transfection
Pathology and Forensic Medicine
Internal medicine
medicine
Animals
Humans
Codon
Muscle
Skeletal

Molecular Biology
Alleles
Cell Nucleus
Electromyography
Lysine
Myocardium
Cell Membrane
Wild type
Muscle
Smooth

DNA
Cell Biology
medicine.disease
Molecular biology
Endocrinology
Amino Acid Substitution
Limb-girdle muscular dystrophy
Zdroj: Laboratory Investigation. 88:275-283
ISSN: 0023-6837
DOI: 10.1038/labinvest.3700713
Popis: Caveolins are the principal protein components of caveolae, invaginations of the plasma membrane involved in cell signaling and trafficking. Caveolin-3 (Cav-3) is the muscle-specific isoform of the caveolin family and mutations in the CAV3 gene lead to a large group of neuromuscular disorders. In unrelated patients, we identified two distinct CAV3 mutations involving the same codon 78. Patient 1, affected by dilated cardiomyopathy and limb girdle muscular dystrophy (LGMD)-1C, shows an autosomal recessive mutation converting threonine to methionine (T78M). Patient 2, affected by isolated familiar hyperCKemia, shows an autosomal dominant mutation converting threonine to lysine (T78K). Cav-3 wild type (WT) and Cav-3 mutations were transiently transfected into Cos-7 cells. Cav-3 WT and Cav-3 T78M mutant localized at the plasma membrane, whereas Cav-3 T78K was retained in a perinuclear compartment. Cav-3 T78K expression was decreased by 87% when compared with Cav-3 WT, whereas Cav-3 T78M protein levels were unchanged. To evaluate whether Cav-3 T78K and Cav-3 T78M mutants behaved with a dominant negative pattern, Cos-7 cells were cotransfected with green fluorescent protein (GFP)-Cav-3 WT in combination with either mutant or WT Cav-3. When cotransfected with Cav-3 WT or Cav-3 T78M, GFP-Cav-3 WT was localized at the plasma membrane, as expected. However, when cotransfected with Cav-3 T78K, GFP-Cav-3 WT was retained in a perinuclear compartment, and its protein levels were reduced by 60%, suggesting a dominant negative action. Accordingly, Cav-3 protein levels in muscles from a biopsy of patient 2 (T78K mutation) were reduced by 80%. In conclusion, CAV3 T78M and T78K mutations lead to distinct disorders showing different clinical features and inheritance, and displaying distinct phenotypes in vitro.
Databáze: OpenAIRE